The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Danielle Walker, 36, plans to undergo immunotherapy treatment in Germany which costs £35,000 a course :: The family has ...

Our findings demonstrate that the mutational landscape of BPDCN is similar to that observed in other myeloid neoplasms, and we identified CCDC50 as a ...

Scientists have pinpointed a crucial network of immune cells that allows humans to digest food safely without triggering ...

2025年6月，美国生物技术公司Diakonos Oncology宣布完成200万美元的SAFE（Simple Agreements for Future ...

The study aims to uncover the immunological basis of Tanshi (phlegm-dampness) constitution—a subhealth type in traditional ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

The study aims to uncover the immunological basis of Tanshi (phlegm-dampness) constitution—a subhealth type in traditional Chinese medicine ...

Men around the world dealing with sexual impotence have been treated for years with the drug sildenafil, sold under brand ...